Navigation Links
KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K
Date:3/25/2008

ST. LOUIS, March 25 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVA/KVB), a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets technology differentiated branded and generic/non-branded prescription pharmaceutical products, announced the filing of its fiscal 2007 Form 10-K with the Securities and Exchange Commission.

The filing includes restatements of previously reported results for fiscal years 1995 through 2006. In addition, the Company filed a Form 10-QA for the quarter ended June 30, 2006 and Form 10-Q's for the quarters ended September 30, 2006 and December 31, 2006. These filings complete the Company's previously announced restatement of financial results. The financial statements for fiscal 2007 included in the Form 10-K filed with the Securities and Exchange Commission are consistent with the previously reported unaudited financial information which was detailed in a press release dated February 15, 2008.

The Company is currently in the process of completing its Form 10-Q's for the fiscal quarters ended June 30, 2007, September 30, 2007 and December 31, 2007. The filing of the fiscal 2007 10-K brings the Company into compliance with the annual reporting conditions for continued trading on the New York Stock Exchange. However, KV will remain on the NYSE late filer list until its fiscal 2008 quarterly filings are completed.

The Company's filings have been delayed due to the previously reported investigation by a Special Committee of independent members of the Board of Directors into the Company's former stock option grant practices. The investigation concluded that no employee, officer or director of the Company engaged in any intentional wrongdoing or was aware that the Company's policies and procedures for granting and accounting for stock options were materially non-compliant with U.S. Generally Accepted Accounting Principles. The investigation also found no intentio
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. AUDIO from Medialink and Solvay Pharmaceuticals: Men with Type 2 Diabetes at Increased Risk for Low Testosterone Should Talk to Their Doctors
2. MAP Pharmaceuticals Appoints H. Ward Wolff to Board of Directors
3. Sales and Marketing Effectiveness in Pharmaceutical Companies Increases Brand Performance
4. Conatus Pharmaceuticals Appoints Anthony W. Fox, MD, Ph.D., as Chief Medical Officer
5. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
6. Dreier LLP Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated (VRTX)
7. Alseres Pharmaceuticals, Inc. Raises $5 Million
8. Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals
9. Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
10. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated
11. Sagent Pharmaceuticals Launches Ciprofloxacin Injection, USP, 5% Dextrose Premix Bag
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... The report segments the European ... care, end user, accessory, and region. The medical ... the European patient handling equipment market, by product. ... grow at the highest CAGR in the forecast ... http://www.marketsandmarkets.com/Market-Reports/european-patient-handling-equipment-market-109569718.html , On the basis of type ...
(Date:2/26/2015)... February 26, 2015 Dr. Parsa Mohebi, a ... hair transplant contest winner’s surgery on Friday, February ... Marc R., is all set to receive his grand prize ... system. His procedure will be done on a live feed ... watch the surgery, go to the website and experience everything ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Wound ... center management, recently expanded its executive team by adding ... industry experience. At the same time two WCA team ... Wound Care Advantage (WCA) was founded in 2002 and ... still operating today. The WCA team believes that providing ...
(Date:2/26/2015)... NY (PRWEB) February 26, 2015 The ... with Topical BioMedics, Inc., Rhinebeck, NY, to offer customers ... creams—patented topical biomedicine formulas that safely and effectively address ... a new division of Vets Access LLC, Montrose, MI, ... and healing products. , Topical BioMedics is a research ...
(Date:2/26/2015)... Participants in the April 16 virtual ... What’s New? ,” will learn how to fine-tune ... outcomes for duals-plan members and plans alike. ... phase of programs for Medicare-Medicaid dual eligibles? What ... to be implemented in the future? Participants in ...
Breaking Medicine News(10 mins):Health News:European Patient Handling Equipment Market Hit to $5,150.2 Million by 2019 - New Resaerch Report by MarketsanMarkets 2Health News:European Patient Handling Equipment Market Hit to $5,150.2 Million by 2019 - New Resaerch Report by MarketsanMarkets 3Health News:Hair Transplant Contest Winner’s Surgery to be Streamed LIVE 2Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 2Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 3Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 4Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 2Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 3Health News:Upcoming AIS Virtual Conference Will Explain What Is and Is Not Working in Medicare-Medicaid Dual Eligibles Programs 2
... A team led by scientists at The Scripps Research Institute has ... to survive when they spread to distant organs. The finding could ... tumors. A cell that breaks away from the primary tumor ... a new organ, normally is destroyed by a process known as ...
... -- Newly discovered mutations in two adjacent genes cause a ... new study. People with Joubert syndrome have malformation or ... of physical and mental disabilities such as poor muscle control ... people with Joubert syndrome meet the criteria for an autism ...
... World Health (DWH), a leading medical charity based ... treatments for neglected tropical diseases, has signed a ... Parasitic Drug Development (CPDD), based at The University ... The collaboration agreement to develop new drugs is ...
... (January 26, 2012) Mark your calendars, the Breast ... University Medical Center, one of the nation,s top 50 cancer ... Antonio Breast Cancer Symposium on Friday, February 17 from 7:00 ... Jersey Breast Cancer Conference. The San Antonio Breast Cancer ...
... (HealthDay News) -- The human papillomavirus (HPV) vaccine Gardasil ... lupus, type 1 diabetes or multiple sclerosis, according to ... women. Gardasil is recommended in the United States ... HPV infection, which is the most common sexually transmitted ...
... Research to Prevent Blindness (RPB) has granted Massachusetts ... M.P.H., a $150,000 Senior Scientific Investigator Award. RPB Senior ... research at medical institutions in the United States. ... on viral infections of the eye, and has worked ...
Cached Medicine News:Health News:Scripps research scientists illuminate cancer cells' survival strategy 2Health News:Scripps research scientists illuminate cancer cells' survival strategy 3Health News:Scripps research scientists illuminate cancer cells' survival strategy 4Health News:Scottish medical charity and international drug consortium form partnership 2Health News:JTCC brings leading experts to present 2011 San Antonio Breast Cancer Symposium research 2Health News:Study Finds No Link Between HPV Vaccine and Autoimmune Disorders 2
(Date:2/26/2015)... , Feb. 26, 2015  Lyric Pharmaceuticals Inc. ... financing round totaling $20.4 million. The financing, co-led by ... includes participation by Aperture Venture Partners. ... by David Wurtman , M.D., M.B.A., President & ... M.D., Chief Medical Officer.  In 2014, Lyric closed a ...
(Date:2/26/2015)... February 26, 2015 Vectorious ... cardiac monitoring system for patients suffering from congestive ... closed a $5 million financing round. Investors in ... owned jointly by Yehuda Zisapel and Prof. ... Gilon, Gur Muntzer and others; and the U.S.-based ...
(Date:2/26/2015)... , Feb. 26, 2015  CSSi, ( ... for the clinical research industry, is pleased to ... as a Project Manager, adding significant value ... Photo - http://photos.prnewswire.com/prnh/20150225/177750 ... a demonstrated ability to successfully lead the navigation ...
Breaking Medicine Technology:Vectorious Medical Technologies Completes $5M Raise 2CSSi's Continued Growth Brings Talented New Hire - Karen Welch Welcomed as Project Manager 2
... Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), ... human disease, announced today that Pablo Lapuerta, M.D. has ... for directing clinical development of Lexicon,s drug candidates from ... Lapuerta has 15 years of pharmaceutical industry experience in ...
... March 24, 2011 The pharmaceutical industry has turned to ... pipelines and patent loss. Fixed dose combination (FDC) products not ... products but also the chance to offer payers and patients ... getting to market quickly with an FDC is more myth ...
Cached Medicine Technology:Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer 2Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer 3Successful Strategies and Innovative Practices for Bringing FDC Products to Market 2
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
This fixed-volume digital micropipet is used to accurately measure and transfer 50 microliters of solution....
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... fixed pipette is ideal for ... volume. Fixed volume FInnpipettes offer ... as other Finnpipette Digital pipettes: ... blow-out (1-40ul), Soft-touch tip ejection, ...
Medicine Products: